Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from GSK

Health warning as cases of little known disease skyrocket and 'tripledemic' looms

Health officials are endorsing two new vaccines against respiratory syncytial virus (RSV) for older Americans, alongside flu and Covid-19 vaccines, although there are uncertainties about the risks

Daily Mirror

Tech spending: The companies on London’s blue chip index exploring AI

A host of FTSE 100 companies are among businesses planning to invest in AI

Evening Standard

Older Americans can get RSV vaccine this fall after speaking with their doctor, CDC says

Americans 60 and older can get a new RSV vaccine but should discuss it with their doctor first

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Gamechanging’ TB vaccine within reach after $500m pledge to run final trials

Joint deal between Gates Foundation and Wellcome to develop M72 jab could save 8.5 million lives and prevent 76 million cases

The Guardian - UK

Gonorrhea shot gets FDA fast track as resistant cases multiply

GSK Plc’s experimental gonorrhea vaccine got fast-track designation from U.S. regulators, putting the shot in position to become the first preventive for a common, often-undetected infection that’s gaining resistance to treatment.

Tribune News Service

How big pharma is using AI to untangle the language of DNA

AI-powered tools are rapidly transforming the world of drug discovery

Evening Standard

GSK settles lawsuit over heartburn drug allegedly linked to cancer

The drug was owned by GSK but distribution was halted and it was recalled in 2019

Wales Online

Read news from The Economist, FT, and more,
with one subscription

A+E Works With Ad Client GSK To Produce Meningitis B Awareness Film

Short features Soleil Moon Frye, Melissa Joan Hart

Multichannel News

Vivek Ramaswamy is threatening GOP heavyweights in the polls–but his business record doesn't live up to the hype

Yale's Sonnenfeld and Tian retrace presidential hopeful Vivek Ramaswamy's business record.

Fortune

GSK CEO Emma Walmsley says A.I. could improve Big Pharma's most 'profound' challenge: R&D inefficiency

"When we talk about health care costs, the single biggest thing we can do is innovate more.”

Fortune

GSK’s CEO says you need thick skin if you’re going to step into the C-suite

Emma Walmsley reflects on what it takes to lead a company through a turnaround.

Fortune

Why GSK's Emma Walmsley 'violently rejects' the idea of 'superhero' CEOs

In her mind, leadership is about inspiring collaboration.

Fortune

Being 'nature-positive' has been a hollow aim. That’s about to change

Move over, greenwashing (and greenwishing). Goodbye, vague nature goals. Enter science-based nature targets.

Fortune

Giant turbines in South Ayrshire village would power Irvine pharmaceutical giant's factory

Residents debated whether to pragmatically embrace two turbines, which would power nearby GSK, planned for Dundonald.

Daily Record

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

RSV vaccine for pregnant women protects their newborns but is it ready for US sale?

Federal health advisers are debating a first-of-its-kind RSV vaccine to protect newborns by immunizing their moms late in pregnancy

Businessweek

AI Drug Discovery Is a $50 Billion Opportunity for Big Pharma

Artificial intelligence can shave years off the development process, and companies like Japan’s Takeda are making large investments.

The Hindu

FDA approves first vaccine for respiratory syncytial virus

The FDA has approved the first vaccine for respiratory syncytial virus (RSV).

Chicago Sun-Times

FDA approves 1st RSV vaccine for older adults

After decades of failure in the quest for an RSV vaccine, doctors are anxious to finally have something to offer — especially after a virus surge that strained hospitals last fall.

Get all your
news in one place.

100's of premium titles.
One news app.

LiveScience

FDA approves 1st RSV vaccine

The Food and Drug Administration has approved a vaccine for respiratory syncytial virus (RSV) for use in people ages 60 and older.

The Times of India

World's first respiratory syncytial virus vaccine gets approval: Key points to know

Pharmaceutical company GSK's RSV vaccine has been approved by the US Food and Drug Administration (FDA) to become the world's first such vaccine. Known as Arexvy, this vaccine has been approved after three clinical trials.

Axios

FDA approves United States' first-ever RSV vaccine

GSK's RSV vaccine is approved for people aged 60 and older.

The Independent UK

US approves first vaccine for RSV after decades of attempts

The US has approved the first vaccine for RSV, shots to protect older adults

The Guardian - UK

New CBI boss says she is ‘profoundly sorry’ to women let down by group

Rain Newton-Smith’s tweets came on day she became director general at Confederation of British Industry

Evening Standard

End of the road for Covid turnover, GSK says

GSK has signalled the end of the road for its Covid drug sales boom as the pharma giant eyes fresh sources of revenue to plug the hole left by the subsidence of the pandemic.

Evening Standard

FTSE 100 Live: ‘A radical decline in UK investment’ — London Stock Exchange boss grilled on US listings

GSK, housebuilder Persimmon and the consumer products group Reckitt Benckiser are among the blue-chips updating investors today.

1 … 8 9 10 11

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.